For the Inventor, By the Inventor

Enter inventor name

Framingham, MA, United States of America

John Howard Jones

USPTO Granted Patents = 19 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 144(Granted Patents)

Location History:

Cleveland, OH (US) (1978 - 1979)
South Pasadena, FL (US) (1981)
New Bern, NC (US) (1996)
Stratford, CT (US) (2001 - 2010)
Framingham, MA (US) (2011 - 2023)
Cambridge, MA (US) (2024)

Company Filing History:

The Institute for Pharmaceutical Discovery, LLC

Millennium Pharmaceuticals Limited

Sunesis Pharmaceuticals, Inc.

4. 4 out of 250

The Institutes for Pharmaceutical Discovery LLC

The Institute for Dibetes Discovery LLC

Alinea Pharmaceuticals, Inc.

8. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1978-2025

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12404263 - ASK1 inhibiting agents (2025-09-02),

2. 11999715 - ASK1 inhibiting agents (2024-06-04),

3. 11814362 - ASK1 inhibiting agents (2023-11-14),

4. 10968181 - NRF2 activator (2021-04-06),

5. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity (2018-03-20),

6. 8802657 - Compounds useful as Raf kinase inhibitors (2014-08-12),

7. 8293752 - Compounds useful as Raf kinase inhibitors (2012-10-23),

8. 8163932 - Substituted indolealkanoic acids (2012-04-24),

9. 7968536 - Heterocyclic compounds useful as RAF kinase inhibitors (2011-06-28),

10. 7659269 - Substituted indolealkanoic acids (2010-02-09),

11. 7304079 - Substituted indolealkanoic acids (2007-12-04),

12. 7105514 - Substituted indolealkanoic acids (2006-09-12),

13. 6730794 - Substituted indolealkanoic acids (2004-05-04),

14. 6426344 - Aryl and heteroaryl substituted indolealkanoic acids (2002-07-30),

15. 6214991 - Substituted indolealkanoic acids (2001-04-10),

Title: Spotlight on Inventor John Howard Jones

Introduction:

John Howard Jones, a prolific inventor based in Framingham, MA (US), has made significant contributions in the field of pharmaceuticals with an impressive portfolio of 13 patents to his name.

Latest Patents:

Jones' latest patents showcase his innovative prowess in the pharmaceutical industry. The first patent pertains to ASK1 inhibiting agents, compounds that have shown promise in treating disorders responsive to the inhibition of apoptosis signal-regulating kinase 1 (ASK1). The second patent revolves around NRF2 activators, compounds with potential therapeutic applications, along with methods for their production and use.

Career Highlights:

Having worked at The Institute for Pharmaceutical Discovery, LLC and Millennium Pharmaceuticals Limited, Jones has honed his skills and expertise in drug discovery and development. His extensive experience in these reputable companies has undoubtedly shaped his innovative mindset and propelled his success in the field.

Collaborations:

Throughout his career, Jones has collaborated closely with accomplished individuals such as David Gunn and Michael C Van Zandt. Together, they have synergized their talents and expertise to bring cutting-edge pharmaceutical solutions to the market, further solidifying Jones' reputation as a visionary inventor.

Conclusion:

Inventor John Howard Jones stands as a testament to the power of innovation and dedication in the realm of pharmaceutical research. With his trailblazing patents and collaborative spirit, Jones continues to make strides in advancing the field, inspiring fellow inventors and researchers alike.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…